We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

25 hedge funds and large institutions have $1.32M invested in Grace Therapeutics in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more capital invested

Capital invested by funds: $602K → $1.32M (+$723K)

0.02% more ownership

Funds ownership: 0.04% → 0.06% (+0.02%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

4% less funds holding

Funds holding: 26 → 25 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$506K
2
Citadel Advisors
Citadel Advisors
Florida
+$83.9K
3
Jane Street
Jane Street
New York
+$7.9K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$2.86K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.72K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$56.4K
2
UBS Group
UBS Group
Switzerland
-$21.6K
3
BDF
Balasa Dinverno & Foltz
-$8K
4
CIBC World Market
CIBC World Market
Ontario, Canada
-$6K
5
PAG
Private Advisor Group
New Jersey
-$3.03K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$452K +$506K +17,361 +645%
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$184K – – –
Two Sigma Advisers
3
Two Sigma Advisers
New York
$171K +$2.86K +98 +1%
VF
4
Virtu Financial
New York
$118K +$153K +5,258 New
Citadel Advisors
5
Citadel Advisors
Florida
$99K +$83.9K +2,876 +191%
OC
6
Oppenheimer & Co
New York
$93K – – –
Morgan Stanley
7
Morgan Stanley
New York
$32K -$56.4K -1,934 -58%
JLBC
8
J.L. Bainbridge & Co
Florida
$30K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$28K – – –
SIG
10
Sargent Investment Group
Maryland
$25K – – –
MMPW
11
Mitchell McLeod Pugh & Williams
Alabama
$21K – – –
SIAP
12
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$18K – – –
PAG
13
Private Advisor Group
New Jersey
$14K -$3.03K -104 -14%
UBS Group
14
UBS Group
Switzerland
$9K -$21.6K -742 -65%
FWM
15
Frontier Wealth Management
Missouri
$8K – – –
Jane Street
16
Jane Street
New York
$6K +$7.9K +271 New
SFA
17
Sequoia Financial Advisors
Ohio
$5K – – –
Walleye Trading
18
Walleye Trading
New York
$5K – – –
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$3K +$1.72K +59 +78%
Bank of America
20
Bank of America
North Carolina
$2K – – –
Rockefeller Capital Management
21
Rockefeller Capital Management
New York
$1K – – –
FDCDDQ
22
Federation des caisses Desjardins du Quebec
Quebec, Canada
$970 – – –
RE
23
RBC Europe
United Kingdom
$14 – – –
BDF
24
Balasa Dinverno & Foltz
– -$8K -448 Closed
CIBC World Market
25
CIBC World Market
Ontario, Canada
– -$6K -334 Closed
1
2

GRCE Hedge Fund Activity: Q2 2020 in Review

25 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2020, worth a combined $1.32M — up 120% from $602K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of GRCE and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $506K. The largest seller was Morgan Stanley, cutting an estimated $56.4K.

  • 25 institutional investors held Grace Therapeutics (GRCE) as of Q2 2020, down from 26 in Q1 2020.
  • Funds reported $1.32M of Grace Therapeutics stock for Q2 2020, up 120% quarter-over-quarter.
  • 2 funds opened new Grace Therapeutics positions in Q2 2020 and 3 closed out, a net change of -1 holder.
  • The largest Grace Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $506K added.
  • The largest Grace Therapeutics seller in Q2 2020 was Morgan Stanley, an estimated $56.4K sold.

Based on aggregated 13F filings for Q2 2020.